Search results for "Infectious Diseases"
New guidelines, authorizations on remdesivir, bamlanivimab, other drugs for COVID-19
The World Health Organization and Infectious Diseases Society of America (IDSA) changed their guidelines to be less favorable to remdesivir. Both the IDSA and NIH expressed reservations about bamlanivimab, while the FDA issued two new emergency use authorizations.
https://acphospitalist.acponline.org/weekly/archives/2020/11/25/1.htm
25 Nov 2020
Hospitalists can help eliminate HCV
Hospitals are the latest frontier in global efforts to diagnose and treat hepatitis C virus (HCV).
https://acphospitalist.acponline.org/archives/2023/01/11/free/hospitalists-can-help-eliminate-hcv.htm
11 Jan 2023
Latest COVID-19 research looks at tocilizumab, remdesivir, tracheostomy, readmissions
A living systematic review still didn't find benefit from remdesivir or tocilizumab, but new trials supported their use. Delaying tracheostomy may not help patients or clinicians, another study found, and the first 10 days carry increased readmission risk for COVID-19 patients.
https://acphospitalist.acponline.org/weekly/archives/2020/12/23/1.htm
23 Dec 2020
D-dimer, lung ultrasound, and ICU protocols all helpful, latest COVID-19 research says
D-dimer predicted clots in ICU patients better than scores or other markers, lung ultrasound was an effective triage tool, and a protocol for respiratory failure improved ICU survival early on in the pandemic, recent studies found.
https://acphospitalist.acponline.org/weekly/archives/2020/09/23/1.htm
23 Sep 2020
Test yourself: Infectious diseases
The following cases and commentary, which address infectious diseases, are excerpted from ACP's Medical Knowledge Self-Assessment Program (MKSAP14).
https://acphospitalist.acponline.org/archives/2010/01/ty.htm
15 Jan 2010
Variations, improvement strategies in hospital care for COVID-19
Two new studies looked at the problems of variation in hospital outcomes and transmission in health care settings. Other articles offered strategies to make the most of hospitalists, personalize treatment, predict mortality, and follow the evidence.
https://acphospitalist.acponline.org/weekly/archives/2020/07/22/2.htm
22 Jul 2020
New method and lower dosing of vancomycin could treat MRSA with reduced AKI
Achieving typical area under the curve to minimum inhibitory concentrations of vancomycin was not associated with a lower rate of treatment failure but was associated with increased risk of acute kidney injury (AKI), a study found.
https://acphospitalist.acponline.org/weekly/archives/2019/06/12/3.htm
12 Jun 2019
Electronic registry of CRE carriers may help reduce regional spread, modeling study finds
Hospital participation in an electronic public health registry of patients with carbapenem-resistant Enterobacteriaceae (CRE) may help reduce the number of new carriers and region-wide prevalence.
https://acphospitalist.acponline.org/weekly/archives/2019/05/22/3.htm
22 May 2019
Fewer drugs, more bugs: Antibiotic resistance tops concerns at infectious diseases conference
Antibiotic resistance tops concerns at infectious diseases conference.
https://acphospitalist.acponline.org/archives/2007/11/antibiotics.htm
15 Nov 2007
Fungal infection common in critically ill COVID-19 patients
A retrospective study in Belgium found that risk of pulmonary aspergillosis in mechanically ventilated COVID-19 patients was primarily associated with pre-existing risk factors for invasive mold disease.
https://acphospitalist.acponline.org/archives/2023/09/20/free/fungal-infection-common-in-critically-ill-covid-19-patients.htm
20 Sep 2023